BioSpace News Archive

Business

Nyxoah Reports Third Quarter 2022 Financial and Operating Results

Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, reported financial and operating results for the quarter ended September 30, 2022.

November 8, 2022
·
12 min read
Business

CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress

CohBar, Inc. reported its financial results for the third quarter ended September 30, 2022 and highlighted recent corporate progress.

November 8, 2022
·
9 min read
Biotech Bay

Codexis to Participate in Upcoming Healthcare Conferences in November 2022

Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced that management will participate in three upcoming investor conferences.

November 8, 2022
·
2 min read
Business

Harvard Bioscience Announces Third Quarter 2022 Financial Results “Fighting through challenging times while building the company and new technologies for the future.”

Harvard Bioscience, Inc. announced financial results for the third quarter ended September 30, 2022.

November 8, 2022
·
15 min read
Business

NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update

NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported financial results for the quarter ending September 30, 2022.

November 8, 2022
·
8 min read
Business

OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year

OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended September 30, 2022.

November 8, 2022
·
23 min read
Business

OPKO Health Reports Third Quarter 2022 Business Highlights and Financial ResultsConference call begins at 4:30 p.m. Eastern time today

OPKO Health, Inc. reports business highlights and financial results for the three months ended September 30, 2022.

November 8, 2022
·
10 min read
Business

Anika Reports Third Quarter Fiscal 2022 Financial Results

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its third quarter ended September 30, 2022.

November 8, 2022
·
17 min read
Business

Arcutis Announces Third Quarter 2022 Financial Results and Provides Business Update

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported financial results for the quarter ended September 30, 2022, and provided a business update.

November 8, 2022
·
11 min read
Biotech Bay

Kronos Bio Announces Prioritization of Clinical Portfolio to Focus on Lanraplenib and KB-0742

Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced the prioritization of its clinical portfolio to focus on the development of its next generation SYK inhibitor, lanraplenib, and its CDK9 inhibitor, KB-0742.

November 8, 2022
·
10 min read